交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

林芷柔 2026 Apr 01, 00:00

伊朗霍爾木茲戰略:槓桿封鎖水道以獲取經濟籌碼與全球影響

許景桓 2026 Apr 01, 00:00

黃金市場韌性:應對拋售並延續牛市行情

林芷柔 2026 Apr 01, 00:00

Meta 平台:駕馭法律挑戰與 AI 機遇,尋求投資者潛力

盧昕穎 2026 Apr 01, 00:00

地緣政治緩和與投資者佈局轉變,美股有望迎來反彈契機

許景桓 2026 Mar 28, 00:00

地緣政治動盪重塑美元策略,挑戰其傳統主導地位

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
許景桓 2026 Apr 01, 00:00

伊朗戰事牽動共和黨未來:特朗普政治遺產與接班人選的角力

林芷柔 2026 Apr 01, 00:00

全國「停止君主」集會:抗議移民、伊朗政策與其他行動

許景桓 2026 Apr 01, 00:00

烏克蘭尋求中東新盟友,善用國防專長

許景桓 2026 Apr 01, 00:00

美軍增兵中東 應對伊朗緊張局勢升級

張瑋庭 2026 Apr 01, 00:00

聯準會政策轉向:通膨風險抬頭,升息可能性浮現,市場預期動搖

盧昕穎 2026 Apr 01, 00:00

道達爾能源三月稱霸中東原油市場,創下驚人利潤紀錄

許景桓 2026 Apr 01, 00:00

地緣政治緊張加劇推升油價,布倫特原油逼近歷史月漲幅紀錄

林芷柔 2026 Apr 01, 00:00

美國市場本週焦點:聯準會主席鮑爾發言,勞動數據與經濟不確定性牽動市場

聯絡方式

點差

0.39

點差(%)

0.6329 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

123831255040

流通股份

2041735455

收益日期(下一個)

2001-08-07

現金殖利率 

2026-05-01

除息日

2026-04-02

遠期年股息率

2.52

遠期年現金殖利率

0.0422

每股盈餘

3.46

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot